GlassScriptPhysician profile
Vishal Gupta
NPI 1861507824
$293,262.51
in general payments reported to CMS, 2019-2025
59 companies · $23K in 2025
The $23K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $27K · 2021: $34K · 2022: $62K · 2023: $31K · 2024: $43K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $60K · Travel and Lodging: $16K · Food and Beverage: $15K · Consulting Fee: $6,365 · Long Term Medical Supply Or Device Loan: $282 · Entertainment: $44.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $59,815.75 |
| Travel and Lodging | $16,115.21 |
| Food and Beverage | $15,242.18 |
| Consulting Fee | $6,365.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
| Entertainment | $44.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $88,346.57 | 2019-2025 | Jardiance |
| Amgen INC. | $60,859.36 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $35,284.78 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $22,559.83 | 2022-2025 | Camzyos, Eliquis |
| Lilly USA, LLC | $20,577.84 | 2019-2024 | Jardiance |
| Medtronic, INC. | $14,849.56 | 2021-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Osprey Medical INC | $12,155.00 | 2019 | |
| Cardiva Medical, INC. | $12,056.43 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Savvywire |
| Abbott Laboratories | $5,197.39 | 2019-2025 | Amplatzer Amulet, Portico, Navitor |
| Edwards Lifesciences Corporation | $3,969.37 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Esperion Therapeutics, INC. | $3,830.36 | 2020-2022 | |
| Boston Scientific Corporation | $2,076.19 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Asahi Intecc USA, INC. | $1,304.05 | 2019 | |
| Novartis Pharmaceuticals Corporation | $1,175.39 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,172.21 | 2019-2025 | Lifevest |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $938.42 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $870.68 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $755.92 | 2019-2025 | Impella |
| Biosense Webster, INC. | $627.56 | 2025 | Carto 3, Na |
| Penumbra, INC. | $603.59 | 2019-2025 | Indigo System, Ruby Coil |
| Heartflow, INC. | $455.39 | 2019-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $430.28 | 2019-2025 | Wainua, Farxiga, Brilinta |
| Stryker Corporation | $396.40 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Chiesi USA, INC. | $319.53 | 2022-2025 | Cleviprex, Kengreal |
| Medtronic Vascular, INC. | $253.02 | 2019-2020 | |
| Avertix Medical, INC | $250.00 | 2021 | |
| Kestra Medical Technology Services, INC. | $217.09 | 2022-2024 | Assure Wcd |
| Ge Healthcare | $210.00 | 2019 | |
| Cordis US Corp. | $177.39 | 2024-2025 | Mynxgrip, Radial 360, Mynx Control Venous |
| Novo Nordisk INC | $153.56 | 2024-2025 | Wegovy |
| Biotronik INC. | $104.55 | 2020-2025 | Orsiro Mission |
| Angiodynamics, INC. | $103.58 | 2021-2024 | Alphavac |
| Gilead Sciences, INC. | $98.25 | 2023 | Veklury |
| Cardiovascular Systems INC. | $88.53 | 2019-2020 | |
| Teleflex LLC | $87.12 | 2023-2025 | Manta, Supercross, Guideliner |
| Cardinal Health 200 LLC | $75.55 | 2019-2021 | |
| Bridgebio Pharma, INC. | $65.48 | 2025 | Attruby |
| Irhythm Technologies, INC. | $49.21 | 2024 | Zio Monitor, Zio Xt Patch |
| Lantheus Medical Imaging, INC. | $47.18 | 2022-2023 | Definity |
| Opsens INC. | $44.25 | 2023 | Optowire |
| W. L. Gore & Associates, INC. | $43.63 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Bayer Healthcare Pharmaceuticals INC. | $37.18 | 2025 | |
| Atricure, INC. | $36.67 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $33.92 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $33.02 | 2025 | Opsumit, Uptravi, Opsynvi |
| Ekos Corporation | $30.69 | 2019 | |
| Imperative Care, INC | $30.50 | 2024 | Symphony Catheter |
| Philips North America LLC | $28.74 | 2021-2023 | |
| Amarin Pharma, INC. | $22.33 | 2019 | |
| Becton, Dickinson and Company | $22.21 | 2025 | Rotarexs 6 F X 135 Cm |
| Livanova USA, INC. | $21.82 | 2023 | Lifesparc |
| Kiniksa Pharmaceuticals International, Plc | $19.46 | 2024 | Arcalyst |
| Pfizer INC. | $19.38 | 2023 | |
| Zoll Circulation INC | $17.13 | 2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Bard Peripheral Vascular, INC. | $16.67 | 2023 | Rotarexs 6 F X 135 Cm |
| Preventice Services, LLC | $12.30 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.